Mefloquine, an anti-malaria drug known to cause severe adverse effects including hallucinations, insomnia, panic attacks, nightmares and suicide, may have precipitated a young British teen’s sudden death.

Guidance from the National Institute of Health and Care Excellence (Nice) says: “Mefloquine is associated with potentially serious neuropsychiatric reactions.

Read the full article here.

“Labeling can be confusing, vague, misleading, hidden in medical jargon or missing altogether,” said Rachel Brummert, a patient advocate and FDA special employee. “If prescription labeling were consistent, we could avoid many of the problems caused by inconsistent labeling.”

Read the full article here.